Literature DB >> 1707938

The effect of interferon treatment on 14 human colorectal cancer cell lines: growth and carcinoembryonic antigen secretion in vitro.

C A Toth1, P Thomas.   

Abstract

The effect of interferons (IFNs) on growth inhibition and carcinoembryonic antigen (CEA) secretion by 14 established human colorectal carcinoma cell lines was studied in vitro. The cell lines were characterized by morphologic differentiation, level of CEA production, and rate of growth. All cell lines were treated in vitro with recombinant human IFN (alpha, beta, and gamma) and the effect of treatment on growth rate and CEA secretion determined. Each cell line exhibited an individual pattern of growth inhibition that was independent of degree of differentiation, level of CEA production, and rate of growth. IFN-beta treatment did not increase CEA secretion in any of the cell lines studied. IFN-alpha and IFN-gamma resulted in increased CEA production (2- to 81-fold increase) primarily in the moderately to well-differentiated cell lines. IFN-gamma was a more potent inducer of enhanced CEA secretion than IFN-alpha. The more poorly differentiated cell lines did not produce CEA and could not be induced to do so by any of the IFNs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707938     DOI: 10.1089/jir.1990.10.579

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  5 in total

1.  Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.

Authors:  Regis Zimmer; Peter Thomas
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Aspirin and risk of fatal colon cancer.

Authors:  M Odeh
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

3.  Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer.

Authors:  D M Mahvi; J A Madsen; P L Witt; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

4.  Type I interferon resistance in a colorectal cancer cell line is associated with a more aggressive phenotype in vivo.

Authors:  C A Toth; P Thomas
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

5.  A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.

Authors:  Michael Höpfner; Andreas P Sutter; Alexander Huether; Gudrun Ahnert-Hilger; Hans Scherübl
Journal:  BMC Cancer       Date:  2004-05-21       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.